» Articles » PMID: 29529098

Validation of a MicroRNA Target Site Polymorphism in H3F3B That is Potentially Associated with a Broad Schizophrenia Phenotype

Overview
Journal PLoS One
Date 2018 Mar 13
PMID 29529098
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Despite much progress, few genetic findings for schizophrenia have been assessed by functional validation experiments at the molecular level. We previously reported evidence for genetic linkage of broadly defined schizophrenia to chromosome 17q25 in a sample of 24 multiplex families. 2,002 SNPs under this linkage peak were analyzed for evidence of linkage disequilibrium using the posterior probability of linkage (PPL) framework. SNP rs1060120 produced the strongest evidence for association, with a PPLD|L score of 0.21. This SNP is located within the 3'UTR of the histone gene H3F3B and colocalizes with potential gene target miR-616. A custom miRNA target prediction program predicted that the binding of miR-616 to H3F3B transcripts would be altered by the allelic variants of rs1060120. We used dual luciferase assays to experimentally validate this interaction. The rs1060120 A allele significantly reduced luciferase expression, indicating a stronger interaction with miR-616 than the G allele (p = 0.000412). These results provide functional validation that this SNP could alter schizophrenia epigenetic mechanisms thereby contributing to schizophrenia-related disease risk.

Citing Articles

MicroRNAs in Genetic Etiology of Human Diseases.

Olcum M, Tufekci K, Genc S Methods Mol Biol. 2021; 2257:255-268.

PMID: 34432283 DOI: 10.1007/978-1-0716-1170-8_13.


Effects of HTR1B 3' region polymorphisms and functional regions on gene expression regulation.

Xia X, Ding M, Xuan J, Xing J, Pang H, Yao J BMC Genet. 2020; 21(1):79.

PMID: 32689951 PMC: 7372893. DOI: 10.1186/s12863-020-00886-8.


Deep Feature Selection and Causal Analysis of Alzheimer's Disease.

Liu Y, Li Z, Ge Q, Lin N, Xiong M Front Neurosci. 2019; 13:1198.

PMID: 31802999 PMC: 6872503. DOI: 10.3389/fnins.2019.01198.

References
1.
Kauppi K, Westlye L, Tesli M, Bettella F, Brandt C, Mattingsdal M . Polygenic risk for schizophrenia associated with working memory-related prefrontal brain activation in patients with schizophrenia and healthy controls. Schizophr Bull. 2014; 41(3):736-43. PMC: 4393689. DOI: 10.1093/schbul/sbu152. View

2.
Griffin J, Pan B, Polley M, Hoffman P, Farah M . Measuring nerve regeneration in the mouse. Exp Neurol. 2010; 223(1):60-71. DOI: 10.1016/j.expneurol.2009.12.033. View

3.
Lewis C, Levinson D, Wise L, DeLisi L, Straub R, Hovatta I . Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet. 2003; 73(1):34-48. PMC: 1180588. DOI: 10.1086/376549. View

4.
Malhotra D, Sebat J . CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012; 148(6):1223-41. PMC: 3351385. DOI: 10.1016/j.cell.2012.02.039. View

5.
Threadgill D, Dlugosz A, Hansen L, Tennenbaum T, Lichti U, Yee D . Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. 1995; 269(5221):230-4. DOI: 10.1126/science.7618084. View